24.08.2026 RBI stärkt den Forschungsstandort Wien: 360.000 Euro an den WWTFmore about RBI stärkt den Forschungsstandort Wien: 360.000 Euro an den WWTF
21.08.2026 Closer to laboratories, physicians and doctors: MADx expands its international direct presencemore about Closer to laboratories, physicians and doctors: MADx expands its international direct presence
20.08.2026 University of Vienna: Roadmap of animal biodiversity: largest-ever comparison of chromosome-scale genomesmore about University of Vienna: Roadmap of animal biodiversity: largest-ever comparison of chromosome-scale genomes
20.08.2026 Ten MedUni Vienna innovations on the path to practical applicationmore about Ten MedUni Vienna innovations on the path to practical application
20.08.2026 Diagnosing epilepsy: AIT system saves time and money and reduces the risk of misdiagnosismore about Diagnosing epilepsy: AIT system saves time and money and reduces the risk of misdiagnosis
19.08.2026 MedUni Wien: Neue Strategie könnte Immuntherapie bei Darmkrebs wirksamer machenmore about MedUni Wien: Neue Strategie könnte Immuntherapie bei Darmkrebs wirksamer machen
18.08.2026 Pfizer Austria: Studie beziffert erstmals Ausmaß der Lyme-Borreliose mit 20.000 Arztbehandlungen und 900 Spitalsaufenthalten pro Jahrmore about Pfizer Austria: Studie beziffert erstmals Ausmaß der Lyme-Borreliose mit 20.000 Arztbehandlungen und 900 Spitalsaufenthalten pro Jahr
18.08.2026 EB Research Institute Establishes Strategic Advisory Board to Accelerate Development of Therapies for Patients with Epidermolysis Bullosamore about EB Research Institute Establishes Strategic Advisory Board to Accelerate Development of Therapies for Patients with Epidermolysis Bullosa
14.08.2026 MedUni Vienna: Eight Horizon Europe successes across numerous key research areasmore about MedUni Vienna: Eight Horizon Europe successes across numerous key research areas
14.08.2026 Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agencymore about Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency